Patent · US Active

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

US11173202B2 · kind B2 · utility

0Cited by
23References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 2, 2019
Grant dateNov 16, 2021
Priority date—
Expiry dateJul 6, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.